A list of the latest medical information from Seagull Pharmacy

Current Location：Home>Medical Information

Pembrolizumab Prolongs Survival Over Placebo for Persistent, Recurrent, or Metastatic Cervical Cancer
2022-02-10 15:58:58
Survival among patients with persistent, recurrent, or metastatic cervical cancer who were receiving chemotherapy with or without bevacizumab (...
COVID-19 Vaccines Demonstrate T Cell and Antibody Responses in CLL
2022-02-10 15:48:56
The COVID-19 vaccines induced functional T cell and antibody responses when given to patients with chronic lymphocytic leukemia (CLL), providin...
Induction Ibrutinib/Rituximab Plus R-HCVAD Yields Positive Frontline Activity in Mantle Cell Lymphoma
2022-02-09 16:53:45
Frontline induction treatment with ibrutinib (Imbruvica) and rituximab (Rituxan) followed by rituximab plus hyper-fractionated cyclophosphami...
Evorpacept ± Pembrolizumab/Trastuzumab Appears Safe for Advanced Solid Tumors
2022-02-09 13:45:13
The safety profile of evorpacept with or without pembrolizumab ( Keytruda ) or trastuzumab (Herceptin) supports the use of the regimen in pat...
Frontline Maintenance Selinexor Yields Significant PFS Benefit in Advanced or Recurrent Endometrial Cancer
2022-02-09 11:27:09
Treatment with frontline maintenance selinexor (Xpovio) after a combination chemotherapy regimen resulted in a significant improvement in progres...
Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States
2022-02-09 11:17:26
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that a total of approximately...
PDS0101/Pembrolizumab Achieves Preliminary Objective Response End Point for Advanced Head and Neck Cancer
2022-02-08 16:53:51
Results from the phase 2 VERSATILE-002 trial (NCT04260126), investigating PDS0101 in combination with pembrolizumab ( Keytruda ) for patien...
Fleqsuvy Approved for Spasticity Due to Multiple Sclerosis
2022-02-08 16:42:58
The Food and Drug Administration (FDA) has approved Fleqsuvy (baclofen oral suspension) for the treatment of spasticity resulting from multiple s...
High-Frequency, Low-Dose Acalabrutinib Yields Effective Response in CLL/SLL
2021-12-23 16:21:56
Patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who were treated with high-frequency low-dose acalabrutinib (C...
Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis
2021-12-22 17:42:45
gMG is a rare autoimmune disorder characterised by severe muscle weakness. In gMG, inflammation causes damage at the connection point between ne...

<<
<
30
31
32
>
>>
Jump to Page